Both in Pharmaceuticals
Avalo Therapeutics vs Contineum Therapeutics
Over the past year AVTX returned −57.0% and CTNM returned −11.8%; their daily moves had a correlation of 0.23.
AVTX −57.0% CTNM −11.8%Growth of $1, one year, split-adjusted
| Metric | AVTX | CTNM |
|---|---|---|
| Price | $7.17 | $9.39 |
| Market cap | $384.5M | $353.3M |
| Today | −3.63% | +0.64% |
| 1 month | −52.0% | −27.7% |
| 6 months | −47.7% | −28.9% |
| Year to date | −60.5% | −17.8% |
| 1 year | −60.3% | −13.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 6,517.4× | — |
| Net cash | $400.3M | $236.6M |
| Dividend yield | — | — |
| Volatility (60d) | 114.9% | 117.5% |
| Short % of float | 24.6% | 13.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).